Mapping the breast cancer metastatic cascade onto ctDNA using genetic and epigenetic clonal tracking.

ABSTRACT: Circulating tumour DNA (ctDNA) allows tracking of the evolution of human cancers at high resolution, overcoming many limitations of tissue biopsies. However, exploiting ctDNA to determine how a patient's cancer is evolving in order to aid clinical decisions remains difficult. This is because ctDNA is a mix of fragmented alleles, and the contribution of different cancer deposits to ctDNA is largely unknown. Profiling ctDNA almost invariably requires prior knowledge of what genomic alterations to track. Here, we leverage on a rapid autopsy programme to demonstrate that unbiased genomic characterisation of several metastatic sites and concomitant ctDNA profiling at whole-genome resolution reveals the extent to which ctDNA is representative of widespread disease. We also present a methylation

SUBMITTER: Cresswell GD 

PROVIDER: S-EPMC7101390 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature